TRUXIMA

This brand name is authorized in Austria, Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug TRUXIMA contains one active pharmaceutical ingredient (API):

1 Rituximab
UNII 4F4X42SYQ6 - RITUXIMAB

Rituximab binds specifically to the transmembrane antigen, CD20, a non-glycosylated phosphoprotein, located on pre-B and mature B lymphocytes. The antigen is expressed on >95% of all B cell non-Hodgkin’s lymphomas.

Read about Rituximab

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TRUXIMA Concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01FA01 Rituximab L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FA CD20 (Clusters of Differentiation 20) inhibitors
Discover more medicines within L01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10179R, 10193L, 10576P, 10583B, 10591K, 10593M, 11790M, 11800C, 11804G, 11805H, 11810N, 11813R, 11935E, 11936F, 4613T, 4614W, 4615X, 7257Y, 7258B, 7259C, 9544H, 9611W
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 545120040000407, 545120040000507
Country: CA Health Products and Food Branch Identifier(s): 02478382, 02478390
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 123-MBE-0218
Country: EE Ravimiamet Identifier(s): 1739448, 1770993
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1161167001, 1161167002
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 175351, 418667
Country: FR Base de données publique des médicaments Identifier(s): 64102473, 64237955
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 341657, 346138
Country: HK Department of Health Drug Office Identifier(s): 66443, 66444
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8342, 8343
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1082365, 1085387
Country: NL Z-Index G-Standaard, PRK Identifier(s): 51004, 51012
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 19626, 19647
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100387562, 100463050
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W63707001, W63906001
Country: SG Health Sciences Authority Identifier(s): 15671P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8680614140129, 8699862950244
Country: US FDA, National Drug Code Identifier(s): 63459-103, 63459-104

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.